// App-Quantinova.ai

S041 : Effect of a new topical soft steroid hydrocortisone phosphate 0.335% on treatment of dry eye disease

Researchers

Presenter

  • A. Shortt

Principal Investigators

  • N/A

Medical Centers

  • Alex Shortt Eye Surgery Ltd, Ophthalmology, London, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Genetic Disorder

  • Musculoskeletal

Disease

  • Dry Eye Syndrome

  • Short stature, onychodysplasia, facial dysmorphism, and hypotrichosis

Biomarkers

  • N/A

Drug/Treatment

  • Hyaluronic acid

  • Hydrocortisone

Outcome

  • N/A

Study Design

  • Prospective

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved